End-stage Kidney Disease (on Hemodialysis)
Conditions
Interventions
An interventional study with general rehabilitation performed during dialysis and already commercially available amino jelly leucine 40 (per 100 g: energy 30 kcal, protein 3.0 g, lipid 0 g, carbohydra
Sponsors
Sapporo Medical University, School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have undergone maintenance hemodialysis at Sapporo Medical University Hospital, Obihiro Kosei Hospital, Teine Keijinkai Hospital, or JR Sapporo Hospital, and who obtained consent from patients diagnosed with sarcopenia
Exclusion criteria
Exclusion criteria: Excludes limb deficiency, history of orthopedic surgery within 3 months, age under 18, age 90 and older, history of malignant disease, history of spinocerebellar degeneration, and pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sarcopenia improvement in study subjects after 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in various blood data, body components (lower limb muscle mass, upper limb muscle mass, skeletal muscle index), MIS (Malnutrition Inflammation Score), GNRI (Geriatric Nutritional Risk Index), QIDS-J (Quick Inventry of Depressive Symptomatology) | — |
Countries
Japan
Contacts
Public ContactMasayuki Koyama
Sapporo Medical University, School of Medicine Department of Public Health and Department of Cardiovascular, Renal and Metabolic Medicine
Outcome results
None listed